Búsqueda | Base de datos de la OMS sobre COVID-19

Rapid SARS-CoV-2 Seroprevalence Survey in Central and Western Divisions of Fiji, 2021.

Curtis, Stephanie J; Shah, Abdul W; Ratu, Ana; Wilson, Donald J; Hill, Philip C; Hulcome, Phil; Gaylard, Cathy; Faktaufon, Daniel; Cabemaiwai, Talica; Rabukawaqa, Isireli; Qoriniasi, Tevita; Narayan, Akesh; Nakalevu, Susana; Romakin, Pablo; Tudravu, Jemesa; Fong, James; Walsh, Nick.

Emerg Infect Dis ; 29(1): 226-228, 2023 01.

Artículo en Inglés | MEDLINE | ID: covidwho-2198456

RESUMEN

During November-December 2021, we performed a SARS-CoV-2 seroprevalence survey in Central and Western Divisions of Fiji. A total of 539 participants 8-70 years of age were 95.5% (95% CI 93.4%-97.1%) seropositive, indicating high community levels of immunity. Seroprevalence studies can inform public health responses to emerging SARS-CoV-2 variants.

Asunto(s)

COVID-19 , Humanos , Fiji/epidemiología , COVID-19/epidemiología , SARS-CoV-2 , Estudios Seroepidemiológicos , Anticuerpos Antivirales

RESUMEN

Asunto(s)

ENVIAR RESULTADO:

SELECCIÓN DE REFERENCIAS

DETALLE DE LA BÚSQUEDA